PYC Therapeutics Limited Financial Overview
PYC Therapeutics Limited's market cap is currently AU$869.06M. The company's EPS TTM is AU$-0.046; its P/E ratio is -14.47; PYC Therapeutics Limited is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is AU$-0.07. See an overview of income statement, balance sheet, and cash flow financials.